Fig. 2: Comparison of effects of empagliflozin versus placebo on outcomes by LVEF category. | Nature Medicine

Fig. 2: Comparison of effects of empagliflozin versus placebo on outcomes by LVEF category.

From: Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved

Fig. 2

Effects are shown for the primary outcome (cardiovascular death or hospitalization for heart failure) (a), first hospitalization for heart failure (b), cardiovascular death (c) and total hospitalizations for heart failure (d). Detailed results for all related modeled analyses are shown in Fig. 1.

Back to article page